PHYSIOLOGICAL INDIRECT RESPONSE MODELS CHARACTERIZE DIVERSE TYPES OF PHARMACODYNAMIC EFFECTS

被引:268
作者
JUSKO, WJ
KO, HC
机构
[1] Department of Pharmaceutics, School of Pharmacy, State University of New York at Buffalo
关键词
D O I
10.1038/clpt.1994.155
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A family of four basic physiologic indirect response models has been proposed to account for the pharmacodynamics of drugs that act by way of inhibition or stimulation of the production or loss of endogenous substances or mediators. Such models were applied previously to account for the anticoagulant effects of warfarin, adrenal suppression by corticosteroids, cell trafficking effects of corticosteroids, antipyretic effects of ibuprofen, and aldose reductase inhibition. Additional responses that can be readily characterized with such models include muscular contraction from pyridostigmine, diuresis from furosemide, bronchodilation from terbutaline, prolactin secretion after cimetidine, and potassium suppression by terbutaline. This report shows that indirect response models, rather than ''link'' or ''hypothetical effect compartment'' models, may be more appropriate for diverse drugs when time lags exist between plasma or biophase drug concentrations and the time course of pharmacodynamic responses.
引用
收藏
页码:406 / 419
页数:14
相关论文
共 38 条
  • [1] REGULATION AND KINETICS OF THE ACTIN-MYOSIN-ATP INTERACTION
    ADELSTEIN, RS
    EISENBERG, E
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 1980, 49 : 921 - 956
  • [2] SERUM ACETYLCHOLINE-RECEPTOR ANTIBODIES IN MYASTHENIA-GRAVIS
    ALMON, RR
    APPEL, SH
    [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1976, 274 (MAY28) : 235 - 243
  • [3] DIURETIC EFFECT AND DIURETIC EFFICIENCY AFTER INTRAVENOUS DOSAGE OF FRUSEMIDE
    ALVAN, G
    HELLEDAY, L
    LINDHOLM, A
    SANZ, E
    VILLEN, T
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 29 (02) : 215 - 219
  • [4] CLINICAL-PHARMACOLOGY OF PYRIDOSTIGMINE AND NEOSTIGMINE IN PATIENTS WITH MYASTHENIA-GRAVIS
    AQUILONIUS, SM
    ECKERNAS, SA
    HARTVIG, P
    LINDSTROM, B
    OSTERMAN, PO
    STALBERG, E
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1983, 46 (10) : 929 - 935
  • [5] RED BLOOD-CELL SORBITOL LOWERING EFFECTS AND TOLERANCE OF SINGLE DOSES OF AL1576 (HOE 843) IN DIABETIC-PATIENTS
    AVERBUCH, M
    WEINTRAUB, M
    LIAO, JC
    BRAZZELL, RK
    DOBBS, RE
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 28 (08) : 757 - 761
  • [6] BATESON MC, 1977, LANCET, V2, P247
  • [7] FUROSEMIDE EFFECT ON ISOLATED PERFUSED TUBULES
    BURG, M
    STONER, L
    CARDINAL, J
    GREEN, N
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1973, 225 (01): : 119 - 124
  • [8] A PHARMACOKINETIC PROFILE OF NIZATIDINE IN MAN
    CALLAGHAN, JT
    BERGSTROM, RF
    RUBIN, A
    CHERNISH, S
    CRABTREE, R
    KNADLER, MP
    OBERMEYER, B
    OFFEN, WW
    SCHNECK, DW
    ARONOFF, G
    LASSETER, KC
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1987, 22 : 9 - 17
  • [9] PHARMACODYNAMIC ANALYSIS OF THE FUROSEMIDE-PROBENECID INTERACTION IN MAN
    CHENNAVASIN, P
    SEIWELL, R
    BRATER, DC
    LIANG, WMM
    [J]. KIDNEY INTERNATIONAL, 1979, 16 (02) : 187 - 195
  • [10] DALLMAN M F, 1973, P176